← Open Payments lookup

ANASTASIA KIMANTHI: Open Payments

NPI 1801523485 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,996 in 134 payments from 12 companies in 2025. Trend: 2023 $452 · 2024 $2,033 · 2025 $2,996

Food & beverage: $2,996
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$726
Teva Pharmaceuticals USA, Inc.22$522
Janssen Pharmaceuticals, Inc22$424
Vanda Pharmaceuticals Inc.15$308
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$254
ABBVIE INC.7$184
Axsome Therapeutics, Inc.3$154
E.R. Squibb & Sons, L.L.C.13$149
Alkermes, Inc.5$95
Lundbeck LLC5$83

Products named: INGREZZA, INVEGA SUSTENNA, FANAPT, AUSTEDO XR, CAPLYTA, UZEDY, VRAYLAR, Auvelity.

Industry payments across TX — which companies pay providers there.